| Literature DB >> 23910079 |
Holger Willenbring1, Alejandro Soto-Gutierrez.
Abstract
Liver cell therapies using induced pluripotent stem cells (iPSCs) are in development. A recent paper in Nature by Takebe et al. expands the range of liver diseases that could be treated with iPSC-derived hepatocytes by combining them with endothelial and stromal cells to generate organoids that survive and function extrahepatically.Entities:
Mesh:
Year: 2013 PMID: 23910079 PMCID: PMC3828077 DOI: 10.1016/j.stem.2013.07.014
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633